Detalles de la búsqueda
1.
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.
Blood;
139(22): 3278-3289, 2022 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35196370
2.
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.
Future Oncol;
2023 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36617990
3.
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
Ann Hematol;
100(7): 1733-1742, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34018029
4.
Sonographically Diagnosed Urothelial Thickening in Kidney Allografts: A Noninvasive and Clinically Highly Relevant Marker for the Detection of Acute Rejection.
AJR Am J Roentgenol;
215(1): 148-152, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32097029
5.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol;
20(1): 43-56, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30522969
6.
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.
Oncology;
96(4): 217-222, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30844808
7.
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.
Br J Haematol;
182(4): 504-512, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29873072
8.
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2.
Haematologica;
103(9): 1502-1510, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29880603
9.
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib.
Blood;
125(16): 2497-506, 2015 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25700432
10.
Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre.
BJU Int;
117(5): 775-82, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26053895
11.
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
Br J Haematol;
186(1): 184-188, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30740654
12.
Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma.
Haematologica;
103(6): e249-e251, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29170253
13.
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study.
Blood Adv;
7(18): 5294-5303, 2023 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315225
14.
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.
Clin Cancer Res;
29(14): 2593-2601, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37282671
15.
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts.
Clin Cancer Res;
28(20): 4385-4391, 2022 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35939599
16.
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia.
Blood Adv;
6(11): 3440-3450, 2022 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377947
17.
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study.
J Clin Oncol;
39(34): 3853-3865, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618601
18.
Aversive effects of ethanol in adolescent versus adult rats: potential causes and implication for future drinking.
Alcohol Clin Exp Res;
34(12): 2061-9, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20860614
19.
Functional Adrenal Collision Tumor in a Patient with Cushing's Syndrome.
Case Rep Endocrinol;
2020: 7415762, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33414970
20.
Opportunistic body composition evaluation in patients with esophageal adenocarcinoma: association of survival with 18F-FDG PET/CT muscle metrics.
Ann Nucl Med;
34(3): 174-181, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823231